menu
{ "item_title" : "The Digital Chemist", "item_author" : [" Ahmed El-Rashedy "], "item_description" : "This book outlines how generative AI is transforming pharmaceutical R&D from slow, trial-and-error screening to rapid, computationally driven molecular design. The Productivity Crisis: Generative AI combats the industry's declining efficiency by actively designing purpose-built molecules rather than just evaluating existing chemical libraries. The AI Toolkit: The shift relies on advanced machine learning architectures-including VAEs, GANs, reinforcement learning, and 3D diffusion models-to generate structurally viable candidates. The Data Bottleneck: Because public databases are noisy and biased, successful AI pipelines require rigorous data auditing, transfer learning, and strict synthetic feasibility scoring to tether digital designs to wet-lab reality. The Modern Pipeline: While AI drastically accelerates target identification and de novo hit discovery, expert human chemists remain essential to filter out structural hallucinations before physical synthesis begins. Future Frontiers: Generative design is paving the way for complex multi-target drugs (polypharmacology) and ultra-personalized therapies.", "item_img_path" : "https://covers2.booksamillion.com/covers/bam/6/63/056/278/663056278X_b.jpg", "price_data" : { "retail_price" : "135.00", "online_price" : "135.00", "our_price" : "135.00", "club_price" : "135.00", "savings_pct" : "0", "savings_amt" : "0.00", "club_savings_pct" : "0", "club_savings_amt" : "0.00", "discount_pct" : "10", "store_price" : "" } }
The Digital Chemist|Ahmed El-Rashedy

The Digital Chemist : How Generative AI is Rewriting the Rules of Drug Discovery

local_shippingShip to Me
In Stock.
FREE Shipping for Club Members help

Overview

This book outlines how generative AI is transforming pharmaceutical R&D from slow, trial-and-error screening to rapid, computationally driven molecular design. The Productivity Crisis: Generative AI combats the industry's declining efficiency by actively designing purpose-built molecules rather than just evaluating existing chemical libraries. The AI Toolkit: The shift relies on advanced machine learning architectures-including VAEs, GANs, reinforcement learning, and 3D diffusion models-to generate structurally viable candidates. The Data Bottleneck: Because public databases are noisy and biased, successful AI pipelines require rigorous data auditing, transfer learning, and strict synthetic feasibility scoring to tether digital designs to wet-lab reality. The Modern Pipeline: While AI drastically accelerates target identification and de novo hit discovery, expert human chemists remain essential to filter out structural "hallucinations" before physical synthesis begins. Future Frontiers: Generative design is paving the way for complex multi-target drugs (polypharmacology) and ultra-personalized therapies.

This item is Non-Returnable

Details

  • ISBN-13: 9786630562781
  • ISBN-10: 663056278X
  • Publisher: LAP Lambert Academic Publishing
  • Publish Date: October 2026
  • Dimensions: 9 x 6 x 0.98 inches
  • Shipping Weight: 1.29 pounds
  • Page Count: 440

Related Categories

You May Also Like...

    1

BAM Customer Reviews